DE69734952D1 - Anilide als ACAT-Hemmer - Google Patents

Anilide als ACAT-Hemmer

Info

Publication number
DE69734952D1
DE69734952D1 DE69734952T DE69734952T DE69734952D1 DE 69734952 D1 DE69734952 D1 DE 69734952D1 DE 69734952 T DE69734952 T DE 69734952T DE 69734952 T DE69734952 T DE 69734952T DE 69734952 D1 DE69734952 D1 DE 69734952D1
Authority
DE
Germany
Prior art keywords
group
oxygen
compounds
optionally
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69734952T
Other languages
English (en)
Other versions
DE69734952T2 (de
Inventor
Kimiyuki Shibuya
Katsumi Kawamine
Yukihiro Sato
Toshiyuki Edano
Souhei Tanabe
Masami Shiratsuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kowa Co Ltd
Original Assignee
Kowa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co Ltd filed Critical Kowa Co Ltd
Application granted granted Critical
Publication of DE69734952D1 publication Critical patent/DE69734952D1/de
Publication of DE69734952T2 publication Critical patent/DE69734952T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/70—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE69734952T 1996-05-17 1997-05-20 Anilidverbindungen als ACAT-Hemmer Expired - Lifetime DE69734952T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP15874396 1996-05-17
JP15874396 1996-05-17
JP08866097A JP4191269B2 (ja) 1996-05-17 1997-03-25 新規なアニリド化合物及びこれを含有する医薬
JP8866097 1997-03-25

Publications (2)

Publication Number Publication Date
DE69734952D1 true DE69734952D1 (de) 2006-02-02
DE69734952T2 DE69734952T2 (de) 2006-07-27

Family

ID=26430018

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69734952T Expired - Lifetime DE69734952T2 (de) 1996-05-17 1997-05-20 Anilidverbindungen als ACAT-Hemmer

Country Status (7)

Country Link
US (2) US6204278B1 (de)
EP (1) EP0807627B1 (de)
JP (1) JP4191269B2 (de)
AT (1) ATE314352T1 (de)
DE (1) DE69734952T2 (de)
DK (1) DK0807627T3 (de)
ES (1) ES2252765T3 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE297900T1 (de) * 1997-03-25 2005-07-15 Kowa Co Anilidverbindungen und medikamente, die diese enthalten
US6969711B2 (en) 1997-05-26 2005-11-29 Kowa Company, Ltd. Cyclic diamine compounds and medicine containing the same
ES2235328T3 (es) * 1997-05-26 2005-07-01 Kowa Co., Ltd. Nuevos compuestos diamina ciclicos y medicamento que contiene estos compuestos.
ATE321759T1 (de) * 1997-11-14 2006-04-15 Kowa Co Neue amidverbindungen und medikamente die diese enthalten
US6849647B1 (en) 1999-07-21 2005-02-01 Kowa Company, Ltd. Amide compounds and medications containing the same technical field
JP4592130B2 (ja) * 1999-08-05 2010-12-01 大塚化学株式会社 チオ酢酸アミド化合物及び農園芸用殺菌剤
US6622484B2 (en) 2001-02-02 2003-09-23 Caterpillar Inc. Hystat/split torque modulation
WO2003018564A1 (fr) * 2001-08-22 2003-03-06 Kowa Company, Ltd Inhibiteur d'acat selectif de la paroi vasculaire
US7163944B2 (en) * 2004-01-26 2007-01-16 Kowa Co., Ltd. Cyclic diamine compound and pharmaceutical containing the same
ES2439229T3 (es) 2004-10-06 2014-01-22 The Brigham And Women's Hospital, Inc. Relevancia de niveles logrados de marcadores de inflamación sistémica tras el tratamiento
US8633233B2 (en) 2008-08-06 2014-01-21 Hydra Biosciences, Inc. Methods and compositions for treating anxiety
JP5523993B2 (ja) 2010-08-31 2014-06-18 富士フイルム株式会社 酸ハロゲン化物の製造方法、及び酸ハロゲン化物
MY189912A (en) 2013-03-15 2022-03-21 Hydra Biosciences Llc Substituted xanthines and methods of use thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB921791A (en) * 1960-01-21 1963-03-27 Ici Ltd New dyestuffs
US3720686A (en) 1971-04-01 1973-03-13 Squibb & Sons Inc Mercaptobenzimidazole derivatives
DE2961415D1 (en) * 1978-05-20 1982-01-28 Bayer Ag Heteroaryloxy-acetamides, process for their preparation and their use as herbicides
DE2903966A1 (de) 1979-02-02 1980-08-07 Bayer Ag Substituierte carbonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als herbizide
SE460667B (sv) 1979-09-20 1989-11-06 Nippon Chemiphar Co Cyklohexankarboxylsyraderivat, foerfarande foer framstaellning daerav samt naemnda derivat foer terapeutisk anvaendning
GB2093835B (en) 1981-01-22 1984-10-31 Nippon Chemiphar Co Novel guanidinocyclohexanecarboxylic acid derivatives and a process for producing the same
DE3419994A1 (de) * 1984-05-29 1985-12-05 Hoechst Ag, 6230 Frankfurt Benzoxazolyl- und benzthiazolyl-aminosaeuren, ihre herstellung und verwendung im pflanzenschutz
CA2003283A1 (en) 1988-12-05 1990-06-05 C. Anne Higley Imidazoles for the treatment of atherosclerosis
WO1991004027A1 (en) 1989-09-15 1991-04-04 Pfizer Inc. New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat)
US5668136A (en) 1990-09-25 1997-09-16 Eisai Co., Ltd. Trisubstituted benzene derivatives, composition and methods of treatment
JPH04139172A (ja) * 1990-10-01 1992-05-13 Sankyo Co Ltd α―スルフィニル置換アセトアミド誘導体
US5362878A (en) 1991-03-21 1994-11-08 Pfizer Inc. Intermediates for making N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT)
US5364875A (en) 1992-05-11 1994-11-15 The Du Pont Merck Pharmaceutical Company Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis
US5290801A (en) * 1992-05-29 1994-03-01 The Du Pont Merck Pharmaceutical Company Benzimidazoles for the treatment of atherosclerosis
EP0910565A1 (de) * 1997-02-14 1999-04-28 Bayer Corporation Amidderivate als selektive neuropeptid-y-rezeptoren

Also Published As

Publication number Publication date
ES2252765T3 (es) 2006-05-16
JPH1029986A (ja) 1998-02-03
ATE314352T1 (de) 2006-01-15
EP0807627A2 (de) 1997-11-19
US6825223B2 (en) 2004-11-30
DE69734952T2 (de) 2006-07-27
EP0807627A3 (de) 1997-12-03
US6204278B1 (en) 2001-03-20
DK0807627T3 (da) 2006-04-10
US20020037910A1 (en) 2002-03-28
JP4191269B2 (ja) 2008-12-03
EP0807627B1 (de) 2005-12-28

Similar Documents

Publication Publication Date Title
DK1424330T3 (da) Aktivator for peroxisom proliferator-responsiv receptor delta
PT987254E (pt) Compostos de diamina ciclica, originais, e medicamentos que os contem
GR3036583T3 (en) Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
DK0842661T3 (da) Anvendelse af estrogenagonister og -antagonister til fremstilling af et lægemiddel til behandling af atherosclerose, uafhængigt af lipidsænkning
DE69734952D1 (de) Anilide als ACAT-Hemmer
DK0918776T3 (da) Totalsyntese af antitumor acylfulvener
DE69529619T2 (de) Pyrimidinylpyrazolderivate
ATE372320T1 (de) Cyclische amidderivate
DE60223904D1 (de) Benzylaminanalogen
EP1306369A4 (de) Neue schwefelverbindungen und intermolekulare verbindungen, die diese als komponente enthalten
EP1020451A4 (de) Neue anilidverbindungen und medikamente, die diese enthalten
EA200200462A1 (ru) Производные 2-арилхинолина, их получение и терапевтическое применение

Legal Events

Date Code Title Description
8364 No opposition during term of opposition